Nice to meet you!

Our mission

To get proven medical devices and diagnostics into the hands of clinicians faster by giving manufacturers one experienced partner, from first concept to first revenue.

Who we are, and what we do

Emei is a one-stop shop for medical devices and diagnostics companies taking a product to market. Our team brings more than 100 years of combined experience in commercial leadership, clinical development and marketing, gained in blue-chip companies and refined in start-ups around the world. We are European-based and work across Europe, the Middle East, Africa and Asia, tailoring our support to where you are in your product’s life cycle.

Strategy and launch planning

From concept and pre-registration market analysis to a launch plan built around your budget and designed for maximum impact. We know from experience what works, what doesn’t and how to reach your first revenue sooner.

Services

Analysis of Commercial Opportunity

  • Clinical Need
  • Market analysis
  • Product development/final design
  • Cost of goods vs. market pricing
  • KOL Identification

Pre-Launch

  • Regulatory data
  • Pre-launch clinical studies
  • Brand development
  • Distribution strategy
  • KOL relationship initiation
  • Regulatory filing

Launch

  • Point-of-sale literature
  • Website
  • Product videos
  • Congress planning
  • Medical Education
  • Product Training
  • KOL Management

Post Launch

  • Post-market surveillance
  • KOL roundtables
  • White/Consensus papers
  • Post-market studies
  • Distributor management

Our Approach

Assess

IVDR/MDR classification, a gap analysis of your technical file and clinical data, and a market and reimbursement review for target countries.

Launch

Notified body route, EU authorised representative, import and cold-chain logistics, post-market surveillance, key opinion leader engagement and first reference sites.

Scale

Direct rollout, a single major distribution partner or specialist distributors, whichever best fits the product. Supported by publications and ongoing clinical evidence.
Study, analyse, produce and roll out all marketing and sales tools specific to each stage.

Team

Martijn-Blom
Martijn Blom

Managing Director

Commercial medtech executive with extensive experience in international market development, product launches and building high-performing multidisciplinary teams.

Richard-Hughes
Richard Hughes

Commercial Director

Commercial diagnostics leader with three decades of experience in IVD, specializing in European market development, distributor networks and successful product launches.

Vinicio-Tassani-fotografo-101
Vinicio Tassani

Scientific Director

Life sciences executive with a master’s degree in molecular biology and extensive international experience in molecular diagnostics, global product strategy and clinical market development.

Sestan Marco
Marco Sestan

Communications Director

Communications strategist and creative director focused on brand positioning, integrated campaigns and translating complex ideas into clear, effective narratives.

Some clients we’ve worked with

Drop us a line. We’ll get back to you soon.

Design preview — this form does not send messages yet.

Assess

Objective Establish whether and how your product can succeed in specific countries.
What Emei does IVDR/MDR classification and gap analysis of your technical documentation and performance evidence. Market sizing, competitor mapping and reimbursement review for target countries.
What you provide Technical documentation, NMPA dossier, clinical and analytical data, quality system information.
Output Written assessment report with a regulatory roadmap, evidence plan, target markets and budget.
Indicative timing 6 to 10 weeks

Launch

Objective Achieve compliant market access. First commercial and clinical adoption in a lead market.
What Emei does Coordinate the conformity assessment route and notified body engagement. Set up EU regulatory roles, import and cold-chain logistics, post-market surveillance and vigilance. Establish key opinion leader engagement and first reference sites.
What you provide Manufacturing, quality system (ISO 13485), document updates and product supply.
Output Product legally on the EU market, lead-market launch and first reference sites.
Indicative timing Typically 12 to 24 months, driven by device class and notified body capacity.

Scale

Objective Build sustainable revenue across priority markets.
What Emei does Distributor selection, contracting and training. Market-by-market registration where required. Evidence generation, publications and guideline engagement.
What you provide Reliable supply, pricing framework, technical support and joint planning.
Output Multi-country commercial network with agreed revenue targets.
Indicative timing Ongoing, reviewed annually.

Cerca Biotech/Shuwen Biotech

  • Breast cancer molecular diagnostics
  • Set up Cerca Biotech as a vehicle for EMEA and global markets
  • Established an initial clinical dataset
  • Established initial distribution
  • Established an EMEA partnership with Sysmex
  • KOL management
  • 20+ publications
  • 2 white papers
  • Sales in more than 10 countries
  • 20+ clinical and trade shows

Entegrion

  • Point-of-care thromboelastography
  • Initiated in-market clinical evaluations
  • Initiated European distribution agreements
  • Attended several European clinical meetings
  • Established KOL relationships

iXensor

  • UK-focused product launches
  • Point-of-care fertility and wellness
  • 2 large-scale product validation studies
  • Over-the-counter and Amazon sales operations
  • Presented at several key clinical shows

Myriad Genetics

  • Development of International Brand identity for Myriad Genetics
  • Product collection kits development for hereditary breast and ovarian cancer, companion diagnostics, prostate cancer, melanoma, lung cancer and rheumatoid arthritis.
  • Development of Marketing Tools
  • Product Training and Medical Education sessions
  • Distributor coordination in EMEA, LATAM and Asia Pacific
  • 20+ clinical/trade shows
  • Organization of Scientific symposia

PulmonX

  • Development of International Tradeshow booths in Italy and Germany

Sequana Medical

  • Hire and retain an EU and US sales team
  • Market analysis of US hospital for market potential and revenue model
  • Build deep and lasting relationships with KOL’s and those influential in the purchasing process
  • Organize KOL meetings for white paper publishing and tradeshow presentation at scientific meetings
  • Organized Health Care Economics & Reimbursement Strategy for in- and outpatient reimbursement
  • Create new codes in the CPTIII system for a new breakthrough device
  • Opening of first US centers adopting new technology